The impact of COVID-19 pandemic on treatment for metastatic kidney cancer
A recent online survey involving 41 kidney cancer experts worldwide [...]
Funding approved for avelumab in combination with axitinib for untreated advanced kidney cancer
KCSN are formal consultants to NICE and part of the [...]
Encouraging results from two COVID-19 vaccine trials
Encouraging results have been published for two phase 1/2 COVID-19 [...]
Delay in cancer diagnosis during COVID-19 – what next?
This article in The Lancet describes the impact of the [...]
Combination of potential biomarkers may help predict response to immunotherapy in kidney cancer
Currently, it is difficult for clinicians to decide which patients [...]
Study shows steep rise in people waiting for cancer tests
The results from two studies have been released to show [...]
Impact of COVID-19 on the treatment of metastatic kidney cancer
Because so little was known about coronavirus at the start [...]
Long term follow-up of immune-related adverse events in cancer survivors
In this study carried out at a single hospital 217 [...]
COVID-19 testing needed for kidney cancer patients
This article from Oncology Nursing News reports the results of [...]
Inflammatory biomarkers for non-metastatic kidney cancer
This study looked at inflammatory biomarkers in the blood for [...]
